Gabriela S.
- Country
- Romania
- Department
- Cardiologie
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Comparative Phase III Trial of Ferric Derisomaltose Versus No Intravenous Iron in Iron-Deficient Patients with Symptomatic Chronic Heart Failure
- Phase 3 Study on Abelacimab Efficacy and Safety in High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
Data & Insights
Has run more than one trial at 121 of 628 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the field of cardiovascular medicine, with particular emphasis on stroke prevention in patients with cardiac conditions.
- Atrial Fibrillation Management
- Stroke Prevention Strategies
- Systemic Embolism Prevention
Their research focuses on advancing therapeutic approaches for patients with atrial fibrillation who are at elevated risk for stroke.
Thrombosis Research
The investigator conducts research in thrombosis prevention and management, exploring innovative therapeutic solutions for blood clotting disorders.
- Anticoagulation Therapy
- Bleeding Risk Assessment
- Thromboembolism Prevention
Their work encompasses the evaluation of novel anticoagulant treatments and their safety profiles in clinical applications.
Clinical Therapeutics
The investigator's expertise extends to comparative therapeutic studies, evaluating the efficacy and safety of different treatment approaches.
- Treatment Optimization
- Risk-Benefit Assessment
- Therapeutic Innovation
Their research aims to enhance therapeutic outcomes through the assessment of novel treatment options in cardiovascular medicine.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.